Pursuant to the Plan, on the Effective Date, Paul Keglevic, Paul Aronzon, Alex Clavel, Elizabeth LaPuma, Henry S. Miller, David Tolley and Vikas Parekh ceased to be directors of the Company and were replaced by Anant Yardi, Jason Yardi, Adnan Ahmad, Arnold Brier, Daniel Ehrmann and Jagannath Iyer.
Departed
Vikas Parekh
Director
WeWork Inc.
Effective
2024-06-11
Filed
June 12, 2024, 7:59 PM ET
Pursuant to the Plan, on the Effective Date, Paul Keglevic, Paul Aronzon, Alex Clavel, Elizabeth LaPuma, Henry S. Miller, David Tolley and Vikas Parekh ceased to be directors of the Company and were replaced by Anant Yardi, Jason Yardi, Adnan Ahmad, Arnold Brier, Daniel Ehrmann and Jagannath Iyer.
Departed
David Tolley
Director
WeWork Inc.
Effective
2024-06-11
Filed
June 12, 2024, 7:59 PM ET
Pursuant to the Plan, on the Effective Date, Paul Keglevic, Paul Aronzon, Alex Clavel, Elizabeth LaPuma, Henry S. Miller, David Tolley and Vikas Parekh ceased to be directors of the Company and were replaced by Anant Yardi, Jason Yardi, Adnan Ahmad, Arnold Brier, Daniel Ehrmann and Jagannath Iyer.
Departed
Paul Aronzon
Director
WeWork Inc.
Effective
2024-06-11
Filed
June 12, 2024, 7:59 PM ET
Pursuant to the Plan, on the Effective Date, Paul Keglevic, Paul Aronzon, Alex Clavel, Elizabeth LaPuma, Henry S. Miller, David Tolley and Vikas Parekh ceased to be directors of the Company and were replaced by Anant Yardi, Jason Yardi, Adnan Ahmad, Arnold Brier, Daniel Ehrmann and Jagannath Iyer.
Departed
David Tolley
Chief Executive Officer
WeWork Inc.
Effective
2024-06-11
Successor
John C. Santora
Filed
June 12, 2024, 7:59 PM ET
On the Effective Date, David Tolley ceased to serve as the Company's Chief Executive Officer.
Departed
Elizabeth LaPuma
Director
WeWork Inc.
Effective
2024-06-11
Filed
June 12, 2024, 7:59 PM ET
Pursuant to the Plan, on the Effective Date, Paul Keglevic, Paul Aronzon, Alex Clavel, Elizabeth LaPuma, Henry S. Miller, David Tolley and Vikas Parekh ceased to be directors of the Company and were replaced by Anant Yardi, Jason Yardi, Adnan Ahmad, Arnold Brier, Daniel Ehrmann and Jagannath Iyer.
Departed
Henry S. Miller
Director
WeWork Inc.
Effective
2024-06-11
Filed
June 12, 2024, 7:59 PM ET
Pursuant to the Plan, on the Effective Date, Paul Keglevic, Paul Aronzon, Alex Clavel, Elizabeth LaPuma, Henry S. Miller, David Tolley and Vikas Parekh ceased to be directors of the Company and were replaced by Anant Yardi, Jason Yardi, Adnan Ahmad, Arnold Brier, Daniel Ehrmann and Jagannath Iyer.
On June 7, 2024, Jack Read, Corporate Controller and Chief Accounting Officer of Citizens Financial Group, Inc. (the “Company”) informed the Company of his decision to resign, effective August 7, 2024, to pursue a career opportunity with an organization outside of the banking sector.
On June 7, 2024, Michael S. Paquette, Executive Vice President, Chief Financial Officer (“CFO”) of Employers Holdings, Inc. (the “Company”), informed the Company of his intention to retire from the Company on March 31, 2025.
On June 6, 2024, Brett P. Seabert, serving as a Director and Audit Committee Chair on the Board of Directors (the “Board”) of Rocky Mountain Chocolate Factory, Inc. (the “Company”), notified the Board of his intention to resign effective June 6, 2024.
On June 10, 2024, Mark A. Tipton provided notice of his resignation from his position as Chief Financial Officer of TriLinc Global Impact Fund, LLC (the “Company”), which will be effective as of June 30, 2024.
Departed
Michael A. Jacobsen
Vice President, Finance, Chief Accounting Officer and Treasurer
On June 10, 2024, Michael A. Jacobsen informed the Board of Directors of Omeros Corporation (“Omeros” or the “Company”) of his intention to retire from his positions as the Company’s Vice President, Finance, Chief Accounting Officer and Treasurer, effective June 30, 2024.
On June 7, 2024, Michael Hartmeier submitted his resignation as a member of the Board of Directors (the "Board") of Full House Resorts, Inc. (the "Company"), effective immediately.
Departed
Mark Mizicko
Executive Vice President and Chief Commercial Officer
Executive Vice President and Chief Commercial Officer, Mr. Mark Mizicko notified the Board of Directors of his intent to retire from his position at the Company effective as of June 14, 2024.
Upon the closing of the Offering and the resulting reduction in the outstanding shares of Class C common stock and Class D common stock, on June [12], 2024, Sean Sullivan, who served as the remaining Class C Director, resigned from the Board in accordance with the Certificate of Incorporation and the Stockholders Agreement.
On June 10, 2024, Anat Ashkenazi, a director of Maravai LifeSciences Holdings, Inc. (the “Company”), informed the Board of Directors of the Company (the “Board”) that she plans to resign from the Board effective as of July 31, 2024, in consideration of the time commitments associated with her pending appointment as Chief Financial Officer of Alphabet Inc.
On June 9, 2024, Mr. Scipio “Max” Carnecchia tendered his resignation as a member of the Board of Directors of Mitek Systems, Inc. (the “Company”) effective immediately.
On June 5, 2024, Christian Lown, Chief Financial Officer (CFO) of Freddie Mac (formally the Federal Home Loan Mortgage Corporation) notified Freddie Mac of his intention to step down from his position as CFO, effective June 28, 2024.
On June 11, 2024, in connection with the closing of the Transaction, Lawrence A. Mendelsohn resigned from his position as Chief Executive Officer of the Company, and the Company appointed Michael Nierenberg to serve as its Chief Executive Officer.
On June 9, 2024, Barbara Nelson, a member of the Board of Directors of the Company (the “Board”), the Chair of the Nominating and Governance Committee of the Board and a member of the Audit Committee of the Board, notified the Company of her decision not to stand for reelection when her current term expires at the Company’s 2024 Annual Meeting of Stockholders.
On June 6, 2024, Mr. Charles “Chuck” L. Prow resigned from his position as a Class I Director of the Company’s Board of Directors, effective June 16, 2024.
Departed
Dennis L. Walsh
Director
Deciphera Pharmaceuticals, Inc.
Effective
2024-06-11
Successor
Toichi Takino and Masayuki Tanigawa
Filed
June 11, 2024, 7:59 PM ET
Ron Squarer, Patricia L. Allen, Edward J. Benz, Jr., Frank S. Friedman, James A. Bristol, Susan L. Kelley, John R. Martin and Dennis L. Walsh resigned as directors of Deciphera
Departed
James A. Bristol
Director
Deciphera Pharmaceuticals, Inc.
Effective
2024-06-11
Successor
Toichi Takino and Masayuki Tanigawa
Filed
June 11, 2024, 7:59 PM ET
Ron Squarer, Patricia L. Allen, Edward J. Benz, Jr., Frank S. Friedman, James A. Bristol, Susan L. Kelley, John R. Martin and Dennis L. Walsh resigned as directors of Deciphera
Departed
Ron Squarer
Director
Deciphera Pharmaceuticals, Inc.
Effective
2024-06-11
Successor
Toichi Takino and Masayuki Tanigawa
Filed
June 11, 2024, 7:59 PM ET
Ron Squarer, Patricia L. Allen, Edward J. Benz, Jr., Frank S. Friedman, James A. Bristol, Susan L. Kelley, John R. Martin and Dennis L. Walsh resigned as directors of Deciphera
Departed
Frank S. Friedman
Director
Deciphera Pharmaceuticals, Inc.
Effective
2024-06-11
Successor
Toichi Takino and Masayuki Tanigawa
Filed
June 11, 2024, 7:59 PM ET
Ron Squarer, Patricia L. Allen, Edward J. Benz, Jr., Frank S. Friedman, James A. Bristol, Susan L. Kelley, John R. Martin and Dennis L. Walsh resigned as directors of Deciphera
Departed
Patricia L. Allen
Director
Deciphera Pharmaceuticals, Inc.
Effective
2024-06-11
Successor
Toichi Takino and Masayuki Tanigawa
Filed
June 11, 2024, 7:59 PM ET
Ron Squarer, Patricia L. Allen, Edward J. Benz, Jr., Frank S. Friedman, James A. Bristol, Susan L. Kelley, John R. Martin and Dennis L. Walsh resigned as directors of Deciphera
Departed
Susan L. Kelley
Director
Deciphera Pharmaceuticals, Inc.
Effective
2024-06-11
Successor
Toichi Takino and Masayuki Tanigawa
Filed
June 11, 2024, 7:59 PM ET
Ron Squarer, Patricia L. Allen, Edward J. Benz, Jr., Frank S. Friedman, James A. Bristol, Susan L. Kelley, John R. Martin and Dennis L. Walsh resigned as directors of Deciphera
Departed
Edward J. Benz, Jr.
Director
Deciphera Pharmaceuticals, Inc.
Effective
2024-06-11
Successor
Toichi Takino and Masayuki Tanigawa
Filed
June 11, 2024, 7:59 PM ET
Ron Squarer, Patricia L. Allen, Edward J. Benz, Jr., Frank S. Friedman, James A. Bristol, Susan L. Kelley, John R. Martin and Dennis L. Walsh resigned as directors of Deciphera
Departed
John R. Martin
Director
Deciphera Pharmaceuticals, Inc.
Effective
2024-06-11
Successor
Toichi Takino and Masayuki Tanigawa
Filed
June 11, 2024, 7:59 PM ET
Ron Squarer, Patricia L. Allen, Edward J. Benz, Jr., Frank S. Friedman, James A. Bristol, Susan L. Kelley, John R. Martin and Dennis L. Walsh resigned as directors of Deciphera
On June 7, 2024, Jonathan Coslet notified Cushman & Wakefield plc (the “Company”) of his decision to resign from the Board, effective immediately, which the Board accepted.
Mario Dell’Aera Jr., David Golden, Michael Huseby, Steven Panagos, Vice Admiral John Ryan, Rory Wallace, and Raphael Wallander resigned from the Company’s Board of Directors.
Mario Dell’Aera Jr., David Golden, Michael Huseby, Steven Panagos, Vice Admiral John Ryan, Rory Wallace, and Raphael Wallander resigned from the Company’s Board of Directors.
Mario Dell’Aera Jr., David Golden, Michael Huseby, Steven Panagos, Vice Admiral John Ryan, Rory Wallace, and Raphael Wallander resigned from the Company’s Board of Directors.
Mario Dell’Aera Jr., David Golden, Michael Huseby, Steven Panagos, Vice Admiral John Ryan, Rory Wallace, and Raphael Wallander resigned from the Company’s Board of Directors.
Mario Dell’Aera Jr., David Golden, Michael Huseby, Steven Panagos, Vice Admiral John Ryan, Rory Wallace, and Raphael Wallander resigned from the Company’s Board of Directors.
Mario Dell’Aera Jr., David Golden, Michael Huseby, Steven Panagos, Vice Admiral John Ryan, Rory Wallace, and Raphael Wallander resigned from the Company’s Board of Directors.
Mario Dell’Aera Jr., David Golden, Michael Huseby, Steven Panagos, Vice Admiral John Ryan, Rory Wallace, and Raphael Wallander resigned from the Company’s Board of Directors.
Hwan-Yoon F. Chung advised EnerSys’ board of directors (the “Board”) of his decision not to stand for re-election to the Board for the upcoming annual meeting of the stockholders in 2024 (the “2024 Annual Meeting”) in order to focus on his other commitments.
Departed
Rabia Gurses Ozden, M.D.
Director
Adverum Biotechnologies, Inc.
Effective
2024-06-10
Successor
Szilárd Kiss, M.D.
Filed
June 11, 2024, 7:59 PM ET
Dr. Ozden notified the Board of her decision to resign from the Board and the Research and Development Committee of the Board, effective June 10, 2024.
Adam Koppel notified Solid Biosciences Inc. (the “Company”) of his decision to resign as a member of the Company’s Board of Directors (the “Board”), effective as of June 11, 2024.
On June 6, 2024, Dr. Whitney Haring-Smith, notified the Company of his decision to resign from the board of directors of the Company (the “Board”) effective immediately.
On June 9, 2024, Li Han, a member of the Board of Directors (the “Board”) of Faraday Future Intelligent Electric Inc., a Delaware corporation (the “Company”), notified the Board that she will resign as a director of the Company for personal reasons, effective immediately.
Departed
Justin M. Grow
Executive Vice President and Chief Administrative Officer
DELTA APPAREL, INC
Effective
2024-06-05
Filed
June 11, 2024, 7:59 PM ET
On June 5, 2024, Justin M. Grow, Executive Vice President and Chief Administrative Officer amended the effective date of his resignation to June 5, 2024.
Recent executive movements from 8-K Item 5.02 filings, source-linked. Cards are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.